about
PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to PathophysiologyImaging Atherosclerosis.Correlation between arterial FDG uptake and biomarkers in peripheral artery disease.Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography.Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels.Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study.Inflammation imaging in atherosclerosisPredictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE studyPrevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study.Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging studyMultimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis.Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction.Impact of bariatric surgery on carotid artery inflammation and the metabolic activity in different adipose tissues.Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteriesCritical mechanical conditions around neovessels in carotid atherosclerotic plaque may promote intraplaque hemorrhage.Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic AneurysmsImaging atherosclerotic plaque inflammation.The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis.Thresholds for Arterial Wall Inflammation Quantified by (18)F-FDG PET Imaging: Implications for Vascular Interventional StudiesOptimization and Reproducibility of Aortic Valve 18F-Fluoride Positron Emission Tomography in Patients With Aortic Stenosis.High Structural Stress and Presence of Intraluminal Thrombus Predict Abdominal Aortic Aneurysm 18F-FDG Uptake: Insights From Biomechanics.FDG PET imaging and cardiovascular inflammation.Molecular imaging of atherosclerosis in translational medicine.Diagnostic and therapeutic strategies for small abdominal aortic aneurysms.Vascular imaging with positron emission tomography.What can we learn about valvular heart disease from PET/CT?PET imaging of inflammation in atherosclerosis.PET imaging of atherosclerosis.18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis.Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis.Imaging unstable plaque.Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans.Molecular imaging of atherosclerosis with integrated PET imaging.CT signal heterogeneity of abdominal aortic aneurysm as a possible predictive biomarker for expansion.Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression.18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging.GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo.HIF-1α and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages.Dual-energy computed tomography imaging to determine atherosclerotic plaque composition: a prospective study with tissue validation.
P50
Q26750798-27CF2E0F-51E6-468D-9677-EF200E0B0411Q26764836-7457AE82-45EF-4B97-8BD3-5E04CA38DE2DQ30436195-468A5DF6-0359-43F4-982B-51024962331DQ30658182-9A7F34E3-049F-44BA-AB3C-648125B46DA4Q33624365-8E1CCA6A-4CF3-4062-90DD-0A5A59BE6CD4Q33624371-4240D43C-DDB1-4D7F-9E07-A15042C62DEAQ33719461-AA0BC035-B3FA-4D08-B55C-2953479D6587Q33956714-EC926664-508A-4A0A-8CAC-D1192A59EE34Q33994603-CF05B8B0-0F6F-48F3-A2CF-0D623132CC10Q35303221-306E8E5E-95B5-44B6-87E8-C6C3232F0C6BQ35936550-C4EA443E-4A17-4E83-9D57-DFAFA1878E66Q36141760-CD01774B-BCC8-4589-961B-19EB8DD59AB8Q36152926-FFFE7CBA-52BE-4FA2-83E9-BD76E867425FQ36218239-B3924528-0DA8-4B2D-A700-CC437F4E74A3Q36220532-75FBAFC3-200B-46E7-A920-4FAD41430D9FQ36792762-757D8B4C-D32C-4DC2-A68B-EC1F6062103EQ37222163-DB9FCA2D-5F8A-43B4-833B-4B92DC78279BQ37296851-7B0646AF-FE9C-44B3-A414-FC3BE525F45DQ37324445-7D9FAF8E-3815-4BC2-9E8C-425E69C8BAE5Q37346535-A1E030DA-7EAD-4276-B518-5BC7B0929C10Q37420117-FC1073E3-2A41-4070-9BE4-6AE385DFEDA4Q37800428-69355454-6505-40B8-B305-B0A614491975Q37822690-981023B9-471A-41A5-9039-8B0E8FDC1E7BQ37838232-38AD49AC-ABFA-4616-BD40-7BA9DE630E30Q37868709-AED87537-A417-4134-8B91-FE971681BB9AQ38135890-ED0A6A25-2A09-4BB5-A24F-BE83B3B3DA11Q38218902-DAAC7D48-8914-4A2F-BC26-4EB156FEE4C1Q38326673-3993C8EF-A937-40A2-9BC4-58CC17D34C20Q38436566-7C729060-90BB-4B53-9571-C83AAC0282B3Q38481051-3A0D5A40-5AC2-4223-A1A0-93BEEA262096Q38858457-201D0CB6-11C0-48BD-8EA5-88E527F99D23Q39061766-2796AABB-6780-4DB7-8DEE-CB29A136CEE3Q39081465-5541177A-CA8B-41F8-9880-968B8D31E0FDQ39250045-2CDAB460-76EB-4D49-AD1F-653DEB5E9EA8Q39293450-E9F04508-71EB-4D12-8C16-C4A86B38329FQ39315993-80572E0D-2930-43F5-869E-360900CE5232Q40373416-CC439144-3C09-44C1-9D5E-9E22EAD28654Q40713301-B4666FC3-4E93-4DE2-A6B7-B8A746BF5C2EQ40980593-352CB2D0-0B22-426E-8471-0B73B1832E20Q41143090-E00538A4-EE2F-4688-B167-FE885AB1602E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
James H Rudd
@ast
James H Rudd
@en
James H Rudd
@es
James H Rudd
@nl
type
label
James H Rudd
@ast
James H Rudd
@en
James H Rudd
@es
James H Rudd
@nl
prefLabel
James H Rudd
@ast
James H Rudd
@en
James H Rudd
@es
James H Rudd
@nl
P106
P31
P496
0000-0003-2243-3117